Probiotics and Prebiotics

Functional Food Product Development

Volumn , Issue , 2010, Pages 146-177

  Sip, Anna ^a   Grajek, Wlodzimierz ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Acute rotavirus related diarrhea treatment rehydration fluids with probiotic; Cholesterol reduction probiotics inhibiting digestible lipid micelles formation; Functional bowel disorders constipation, treatment LAB; Inflammatory bowel disease ulcerative colitis and Crohn's disease; Prebiotic products eliminating negative calcium imbalance; Probiotic products, LAB alleviating lactose intolerance; Probiotic strains, Lactobacillus selection and functional properties; Probiotics and prebiotics lactic acid bacteria (LAB) beneficial effects; Probiotics medical applications immunomodulation; Synbiotics adding fruits to yoghurt

Indexed keywords

EID: 84885570598     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444323351.ch8     Document Type: Chapter

References (130)

1. Anal, A.K. & Singh, H. (2007). Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery. Food Science and Technology, 18, 240-251.
2. Armuzzi, A., Cremonini, F. & Bartolozzi, F. (2001). The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Alimentary Pharmacology and Therapeutics, 15, 163-169.
3. Barbut, F., Richatd, A., Hamadi, K., Chomette, V., Burghoffer, B. & Petit, J.C. (2001). Epidemiology of recurrences of reinfections of Clostridium difficile-associated diarrhea. Journal of Clinical Microbiology, 38, 2386-2388.
4. Barlett, J.G. (2002). Clinical practice. Antibiotic-associated diarrhea. New England Journal of Medicine, 346, 334-339.
5. Beaugerie, L.A., Flahault, F., Barbut, P., Atlan, P., Lalande, V., Cousin, P., Cadilhac, M. & Petit, J.C. (2003). Antibiotic-associated diarrhea and Clostridium difficile in the community. Alimentary Pharmacology and Therapeutics, 17, 905-912.
6. Beijerinck, M.W. (1901). Sur les ferments de lactique de l'industrie. Des Sciences Exactes et Naturelles, 6, 212-243.
7. Blum, S., Reniero, R., Schiffrin, E.J., Cittenden, R., Mattila Sandholm, T., Ouwehand, A.C., Salminen, S., Wright, A., von Saarela, M., Saxelin,M., Collins, K. & Morelli, L. (1999). Adhesion studies for probiotics: reed for validation and refinement. Trends in Food Science and Technology, 10, 405-410.
8. Brandtzaeg, P.,Halstensen, T.S.,Kett,K., Krajci, P., Kvale, D.,Rognum, T.O., Scott, H. & Sollid, L.M. (1989). Immunobiology and immune-pathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology, 97, 1562-1584.
9. Camilleri, M. (2001). Management of the irritable bowel syndrome. Gastroenterology, 120, 652-663.
10. Camilleri, M. (2006). Is there a role for probiotics in irritable bowel syndrome? Digestive and Liver Disease, 38(Suppl.), 266s-269s.
11. Canzi, E., Brighenti, F., Casiraghi, M.C., Del Puppo, E. & Ferrari, A. (1995). Prolonged consumption of inulin in ready to eat breakfast cereals: effects on intestinal ecosystem, bowel habits and lipid metabolism. Cost 92. Workshop on Dietary Fiber and Fermentation in the Colon, Helsinki, Finland.
12. Cats, A., Kuipers, E.J., Bosschaert, M.A., Pot, R.G., Vandenbroucke-Grauls, C.M & Kusters, J.G. (2003). Effect of frequent consumption of Lactobacillus casei-containing milk drink in Helicobacter pyloricolonized subjects. Pharmacology and Therapeutics, 17, 429-435.
13. Chouraqui, J.P., Van Ergoo, L.D. & Fichot, M.C. (2004). Acidified milk formula supplemented with Bifidobacterium lactis: impact infant diarrhea in residential care settings. Journal of PediatricGastroenterology and Nutrition, 38, 288-292.
14. Ciarlet,M. & Esters,M.K. (2001). Interactions between rotavirus and gastrointestinal cells. Current Opinion in Microbiology, 4, 435-441.
15. Commane, D., Hughes, R., Shortt, C. & Rowland I. (2005). The potential mechanisms involved in the ant-carcinogenic action of probiotics. Mutation Research, 591, 276-289.
16. Conrad, P.B., Miller,D.P., Cielenski, P.R & de Pablo, J. (2000). Stabilization and preservation of Lactobacillus acidophilus in saccharide matrices. Cryobiology, 41, 17-21.
17. Coudrary, C., Bellanger, J., Castiglie-Delavand, C., Remesy, C., Vermorel, M. & Rayssignuier, Y. (1997). Effect of soluble and partly soluble dietary fibers supplementation on absorption and balance of calcium, magnesium, iron, zince in healthy young men. European Journal of Clinical Nutrition, 51, 375-380.
18. Cremonini, F., Di Caro, S., Nista, E.C., Bartolozzi, F., Capelli, G., Gasbarrini, G. & Gasbarrini, A. (2002). Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhea. Alimentary Pharmacology and Therapeutics, 16, 1461-1467.
19. Daubioul, C.A., Taper, H.S., Wispelaere, L.D. & Delzenne, N.M. (2000). Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglicerydemia in obsese Zucker rats. Journal of Nutrition, 130, 1314-1319.
20. Delzenne, N.M., Kok, N., Fiordaliso, M.F., Deboyser, D.M., Goethals, F.M. & Roberfroid M.B. (1993). Dietary fructooligosaccharides modify lipid metabolism in rats. American Journal of Clinical Nutrition, 69(1), 64-69.
21. Desmond, C., Ross, R.P., O'callaghan, E., Fitzgerald, G. & Stanton, C. (2002). Improved survival of Lactobacillus paracasei NFBC 338 in spray-dried powders containing gum acacia. Journal of Applied Microbiology, 93, 1003-1011.
22. Desmond, C., Stanton, C., Fitzgerald, G.F., Collins, K. & Ross, R.P. (2001). Environmental adaptation of probiotic lactobacilli towards improvement of performance during spray drying. International Dairy Journal, 11, 801-808.
23. Dianda, L., Hanby, A.M., Wright, N.A., Sebesteny, A., Hayday, A.C. & Owen, M.J. (1997). T cell receptoralpha beta-deficient mice fail to develop colitis in the absence of microbial environment. American Journal of Pathology, 150, 91-97.
24. Dunne, C., Murphy, L., Flynn, S., O'Mahony, L., O'Halloran, S., Feeney, M., Morrissey, D., Thornton, G., Fitzgerald, G., Daly, C., Kiely, B., Quigley, E.M.M., O'Sullivan, G.C., Shanahan, F. & Kevin, J. (1999). Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and human clinical trials. Antonie van Leeuwenhoek, 76, 279-292.
25. FDA/WHO (2001). Health and nutrition properties of probiotics in food including power milk with lactic acid bacteria. Report of a joint FDA/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including power milk with lactic acid bacteria.World Health Organization, Cordoba, Argentina.
26. FDA/WHO (2002). Guidelines for the evaluation of probiotics in food. Report of a joint FDA/WHO working group on drafting guidelines for the evaluation of probiotics in food. World Health Organization, London, Ontario, Canada.
27. Felley, C.P., Corhesy-Theulaz, I., Rivero, J.L., Sipponen, P., Kaufmann, M., Bauerfeind, P., Wiesel, P.H., Brassart, D., Pfeifer, A., Blum, A.L. & Michetti, P. (2001). Favorable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. European Journal of Gastroenterology and Hepatology, 13, 25-29.
28. Femia, A.P., Luceri, C.,Dolara, P.,Giannini,A., Biggeri,A., Salvadori, M.,Clune,Y., Collins, K.J., Paglierani, M. & Caderni, G. (2002). Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethaneinduced colon carcinogenesis in rats. Carcinogenesis, 23, 1953-1960.
29. Fooks, L.J. & Gibson, G.R. (2002). In vitro investigations of the effect of probiotica and prebiotics on selected human intestinal pathogens. FEMS Microbiology Ecology, 39, 67-75.
30. Fukushima, M. & Nakano, M. (1995). The effect of probiotic on fecal and liver lipid classes in rats. British Journal of Nutrition, 73, 701-710.
31. Fuller, R. (1989). Probiotics in man and animals. Journal of Applied Bacteriology, 66, 365-378.
32. Gallaher, D.D. & Khil, J. (1999). The effect of synbiotics on colon carcinogenesis in rats. Journal of Nutrition, 129(Suppl.), 1483s-1497s.
33. Garcia De Castro, A., Bredholt, H., Strom, A.R. & Tunnacliffe, A. (2000). Anhydrobiotic engineering of gram-negative bacteria. Applied and Environmental Microbiology, 66, 4142-4144.
34. Gardiner, G.E., Heinemann, Ch., Baroja,M.L., Bruce, A.W., Beuerman, D.,Madrenas, J. & Reid, G. (2002). Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications. International Dairy Journal 12, 191-196.
35. Gibson, G.R., Beatty, E.R., Wang, X. & Cummings, J.H. (1995). Selective stimulation of bifidobacteria in the colon by oligofructose and inulin. Gastroenterology, 108, 975-982.
36. Gibson, G.R. & Roberfroid, M.B. (1995). Dietary modulation of the human colonic microbiota, introducing concept of prebiotics. Journal of Nutrition, 125, 1401-1412.
37. Girgis,H.S., Smith, J., Luchansky, J.B. & Klaenhammer, T.R. (2003). Stress adaptation of lactic acid bacteria. In: Microbial Stress Adaptation and Food Safety. Yousef, A.E. & Juneja, V.K. (eds), CRC Press, Boca Raton, FL,pp. 159-211.
38. Granato, D., Bergonzelli, G.E., Pridmore, R.D., Marvin, L., Rouvet, M. & Corthesy-Theulaz, I.E. (2004). Cell surface-associated elongation factor Tu mediated the attachment Lactobacillus johnsonii NCC511 (La1) to human intestinal cells and mucin. Infection and Immunity, 72, 2160-2169.
39. Guandalini, S., Pensabene, L., Zikri,M.A., Dias, J.A., Casali, L.G. & Hoekstra, H. (2000). Lactobacillus GG administrated in oral rehydratation solution to children with acute diarrhea: a multicenter European trial. Journal of Pediatric Gastroenterology and Nutrition, 138, 361-365.
40. Guarner, F. & Malagelada, J.R. (2003). Gut flora in health and disease. Lancet, 361, 512-519.
41. Haderstorfer, B., Whitehead, W.E. & Schuster, M.M. (1989). Intestinal gas production from bacterial fermentation of undigested carbohydrate in irritable bowel syndrome. American Journal of Gastroenterology, 84, 375-378.
42. Hart, A.L., Stagg, A.J. & Kamm, M.A. (2003). Use of probiotics in the treatment of inflammatory bowel diseases. Journal of Clinical Gastroenterology, 36, 111-116.
43. Hatakka, K., Martini, J., Korpela, M., Herranen, M., Poussa, T. & Laasanen, T. (2003). Effect of probiotic on the activity and activation of mild rheumatoid arthritis. Scandinavian Journal of Rheumatology, 32, 211-215.
44. Hilton, E., Kolakowski, P., Smith, M. & Singer, C. (1997). Efficiency of Lactobacillus GG as diarrhoeal prevention in Travelers. Journal of Travel Medicine, 4, 41-43.
45. Holzapfel, W.H., Haberer, P., Geisen, R., Bjorkroth, J. & Schillinger, U. (2001). Taxonomy and important features of probiotic microorganisms in food and nutrition. American Journal of Clinical Nutrition, 73, 365-373.
46. Holzapfel, W.H. & Schillinger, U. (2002). Introduction to pre- and probiotics. Food Research International, 35, 109-116.
47. Horwitz, B.J. & Fisher, R.S. (2001). Current concepts: the irritable bowel syndrome. New England Journal of Medicine, 344, 1846-1850.
48. Isolauri, E., Arvola, T., Sutas, Y., Moilanen, E. & Salminen, S. (2000). Probiotics in the management of atopic eczema. Clinical and Experimental Allergy, 30, 1604-1610.
49. Isolauri, E., Kaila, M., Arvola, T.,Majamaa, H., Rantala, I., Virtanen, E. & Arvilommi, H. (1993). Diet during rotavirus enteritis effect jejuna permeability to macromolecules in suckling rats. Podiatry Research, 33, 548-553.
50. Isolauri, E., Kaila, M., Mykkanen, H., Ling, W.H. & Salminen, S. (1994). Oral bacteriotherapy for viral gastroenteritis. Digest Diseases Science, 39, 2595-2600.
51. Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H. & Salminen, S. (2001). Probiotics effect on immunity. American Journal of Clinical Nutrition, 73(Suppl.), 444s-450s.
52. Jaworska, H., Gregorek, H., Nowicka, E. & Madalínski K. (2002). Estimation of the assay to treat hereditary andioedema with the use of probiotics. Wspolczesna Pediatria, Hepatologia i Zywienie Dziecka, 1, 96.
53. Johnson, K.F. (1999). Synthesis of oligosaccharides by bacterial enzymes. Glycoconjugate Journal, 16, 141-146.
54. Kalia, M., Isolauri, E., Soppi, E., Virtanen, E., Laime, S. & Arvilommi, H. (1992). Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus stain. Pediatric Research, 32, 141-144.
55. Kalliomakki, M., Salminen, S., Arvilommi, H. & Isolauri, E. (2001). Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet, 357, 1076-1079.
56. Kato, I., Tanaka, K. & Yokokura T. (1999). Lactic acid bacterium potentially induces the production of interleukin-12 and interferon-gamma by mouse splenocytes. International Journal of Immunopharmacology, 21, 121-131.
57. King, T.S., Elia,M. & Hunter, J.O. (1998). Abnormal clonic fermentation in irritable bowel syndrome. Lancet 352, 1187-1189.
58. Kirjavainen, P.V., Apostolou, E., Salminen, S.J., & Isolauri, E. (1999). New aspects of probiotics - a novel approach in the management of food allergy. Allergy, 54, 909-915.
59. Klaenhammer, T.R. & Kullen, M.J. (1999). Selection and design of probiotics. International Journal of Food Microbiology, 50, 45-57.
60. Koebnick, C., Wagner, I., Leitzmann, P., Stern, U. & Zunft, H.J. (2003). Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Canadian Journal of Gastroenterology, 17, 655-659.
61. Kok, N., Roberfroid, M. & Delzenne, N. (1996). Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. British Journal of Nutrition, 76, 881-890.
62. Kok, N., Taper, H. & Delzanne, N. (1998). Oligofructose modulates lipid metabolism alteration induced by a fat-rich diet in rats. Journal of Applied Toxicology, 18, 47-53.
63. Kyne, L. & Kelly, C.P. (2000). Recurrent Clostridium difficile diarrhea. Gut, 49, 152-153.
64. Lacroix, C.H. & Yildirim, S. (2007). Fermentation technologies for the production of probiotics with high viability and functionality. Current Opinion in Biotechnology, 2, 176-183.
65. Lee, C.H. & Salminen, S. (1997). The coming age of probiotics. Trends in Food Science and Technology, 6, 241-245.
66. Levy, J. (2000). The effect of antibiotics on gastrointestinal function. American Journal of Gastroenterology, 95(Suppl.), 8-10.
67. Ling,W.H., Hanninen, O., Mykkanen, H., Heikura, M., Salminen, S. & von Wright, A. (1992). Colonization and fecal enzymes activities after oral Lactobacillus GG administration in elderly nursing home resident. Annals of Nutrition and Metabolism, 36, 162-166.
68. Ling, W.H., Korpella, H., Mykkanen, H., Salminen, S. & Hänninen, O. (1994). Lactobacillus strain GG supplementation decreases colonic hydrolytic activity and reductive enzyme activities in healthy female adults. Journal of Nutrition, 124, 18-23.
69. Liong, M.T. & Shah, N.P. (2005). Acid and bile tolerance and cholesterol removal ability of Lactobacillus strains. Journal of Dairy Science, 88, 55-66.
70. Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L. & De Simone, C. (2001). Probiotic bacteria enhance mureine and human intestinal epithelial barrier function. Gastroenterology, 121, 580-591.
71. Majamaa, H. & Isolauri, E. (1997). Probiotics: a novel approach in the management of food allergy. Journal of Allergy and Clinical Immunology, 99, 179-185.
72. Marteau, P. (2001). Safety aspects of probiotic products. Scandinavian Journal of Nutrition, 45, 22-24.
73. Marteau, P., Pochart, P., Dore, J., Bera-Maillet, C., Bernalier, A. & Corthier, G. (2001). Comparative study of bacterial grups within the human cecal and fecal microbiota. Applied and Environmental Microbiology, 67, 4939-4942.
74. McCarthy, J., O'Mahony, L., O'Callaghan, L., Sheil, B., Vaughan, E.E., Fitzsimons, N., Fitzgibbon, J., O'Sullivan, G.C., Kiely, B., Collins, J.K. & Shanahan, F. (2003). Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut, 2, 975-980.
75. McFarland, L.V. (2006). Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. American Journal of Gastroenterology, 101, 812-822.
76. McFarland, L.V., Surawicz, C.M., Greenberg, R.N., Fekety, R., Elmer, G.W., Moyer, K.A., Melcher, S.A., Bowen, K.E., Cox, J.L., Noorani, Z., Harrington, G., Rubin, M. & Greenwald, D. (1994). A randomised placebo-controlled trial of Saccharmomyces bulardii in combination with standard antibiotics for Clostridium difficile disease. Journal of American Medical Association, 271, 1913-1918.
77. Meyer, M.L., Micksche, M., Herbacek, I. & Elmadfa, I. (2006). Daily intake of probiotic as well as conventional yogurt has a stimulating effect on cellular immunity in young healthy women. Annals Nutrition and Metabolism, 50, 282-289.
78. Mishra, V. & Prasad, D.N. (2005). Application in vitro methods for selection of Lactobacillus casei strains as potential probiotics. International Journal of Food Microbiology, 103, 109-115.
79. Moro, E. (1900).Uber den Bacillus acidophilus n. spec. EinBeitrag zurKenntnis der normalenDarmbakterien des Säuglings (Bacillus acidophilus n. spec.). Jahrbuch f̈ur Kinderheilkunde, 52, 38-55.
80. Mrukowicz, J., Krobicka, B. & Duplaga, M. (1999). Epidemiology and impact of rotavirus diarrhoea in Poland. Acta Pediatrica, 426(Suppl. 1), 53-60.
81. Naruszewicz, M., Johansson, M.L., Zapolska-Downar, D. & Bukowska, H. (2001). Effect of Lactobacillus plantarum 299v on cardiovascular risk factors in smokers. Czynniki ryzyka, 19, 3-4.
82. Nase, L., Hatakka, K., Savilathi, E., Saxelin, M., Ponka, A. & Poussa, T. (2001). Effect of long-term consumption of a probiotic bacterium of Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Research, 35, 412-420.
83. Niedzielin, K., Kordecki, H. & Birkenfeld, B. (2001). A controlled double-blind, randomized study on the efficiency of Lactobacillus plantarum 299v in patients with irritable bowel syndrome. European Journal of Gastroenterology and Hepatology, 13, 1143-1147.
84. Nishina, P. & Freeland, R. (1990). Effect of propionate on lipid biosynthesis in isolated hepatocytes. Hepatology, 16, 1350-1356.
85. Nobaek, S., Johansson, M.L., Molin, G., Ahrné, S. & Jeppsson, B. (2000). Alteration of intestinal microflora is associated with reduction in abdominal bloating pain in patientswith irritable bowel syndrome. American Journal of Gastroenterology, 95, 1231-1238.
86. Ouwehand, A.C., Lagström,H., Suomalainen, T. & Salminen, S. (2002a). Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Annals of Nutrition and Metabolism, 46, 159-162.
87. Ouwehand, A.C., Salminen, S. & Isolauri, E. (2002b). Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek, 82, 279-289.
88. Pessi, T., Sutas, Y., Hurme, M. & Isolauri, E. (2000). Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clinical and Experimental Allergy, 30, 1804-1808.
89. Playne, M., Bennet, L.E. & Smithers, G.W. (2003). Functional dairy foods and ingredients. The Australian Journal of Dairy Technology, 58, 242-264.
90. Plumer, S., Weaver, M.A., Harris, J.C., Dee, P. & Hunter, J. (2004). Clostridium difficile pilot study: effects of probiotic supplementation on incidence of C. difficile diarrhea. International Microbiology, 7, 59-62.
91. Pool-Zobel, B.L., Neudecker, C., Domizlaff, I., Ji, S., Schillinger, U., Rumney, C., Moretti, M., Vilarini, I., Scasellati-Sforzolini, R. & Rowland, I.R. (1996). Lactobacillus-and bifidobacterium-mediated antigenotoxicity in colon of rats. Nutrition and Cancer, 26, 365-380.
92. Rafter, J.J. (1995). The role of lactic acid bacteria in colon cancer prevention. Scandinavian Journal of Gastroenterology, 30, 497-502.
93. Reid, G., Jass, J., Sebulsky, M.T. & McCormick, J.K. (2003). Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews, 16, 658-672.
94. Rivero-Urgell, M. & Santamaria-Orleans, A. (2001). Oligosaccharides: application in infant food. Early Human Development, 65, 43-52.
95. Roberfroid, M.B. (2000). Prebiotics and probiotics: are they functional foods? American Journal of Clinical Nutrition, 71(Suppl.), 1682s-1690s.
96. Roberfroid,M.B. (2001). Prebiotics: preferential substances for specific germs? American Journal of Clinical Nutrition, 73(Suppl.), 406s-409s.
97. Saarela, M., Mogensen, G., Fonden, R.,Matto, J. & Mattila-Sand- Holm, T. (2000). Probiotic bacteria: safety, functional and technological properties. Journal of Biotechnology, 84, 197-215.
98. Saavedra, J., Bauman, N.A., Oung, I., Perman, J. & Yolken, R. (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet, 344, 1046-1049.
99. Sakamoto, S., Igarashi, M., Kimura, K., Takagi, A., Miwa, A. & Koga, Y. (2001). Suppressive effect of Lactobacillus gasseri OLL2716 (LG21) on Helicobacter pylori infection in humans. Journal of Antimicrobial Chemotherapy, 47, 709-710.
100. Salem, M.M.E., Fathi, F.A. & Awad, R.A. (2005). Production of probiotic ice cream. Polish Journal of Food and Nutrition Science, 14, 267-271.
101. Salminen, S., Ouwehand, A., Benno, Y. & Lee, Y.-K. (1999). Probiotics: how should they be defined? Trends Food Science and Technology, 10, 107-110.
102. Saarela, M., Lähteenmäki, L., Crittenden, R., Salminen, S. & Mattila-Sandholm, T. (2002). Gut bacteria and health foods - the European perspective. International Journal of Food Microbiology, 78, 99-117.
103. Saxelin, M., Tynkkynen, S., Mattila-Sanholm, T. & de Vos, W.M. (2005). Probiotic and other functional microbes: from markets to mechanisms. Current Opinion in Biotechnology, 16, 204-211.
104. Schafsma, G., Meuling, W.J.A., Dokkum, W. & Bouley, C. (1998). Effect of a milk product, fermented by Lactobacillus acidophilus with fructo-oligosaccharides added, on blood lipids in male volunteers. European Journal of Clinical Nutrition, 52, 436-440.
105. Scholz-Ahrens, K.E., Schaafsma, G., van den Heuvel, E.G.H.M. & Schrezenmeir, J. (2001). Effects of prebiotics on mineral metabolism. American Journal of Clinical Nutrition, 73(Suppl.), 459s-464s.
106. Schrezenmeir, J. & de Vrese, M. (2001). Probiotics, prebiotics, and synbiotics - approaching a definition. American Journal of Clinical Nutrition, 73(Suppl. 2), 361S-364S.
107. Selmer-Olsen, E., Sorhaug, T., Birkeland, S.E. & Pehrson, R. (1999). Survival of Lactobacillus helveticus entrapped in Ca-alginate in relation to water content, storage and rehydratation. Journal of Industrial Microbiology and Biotechnology, 23, 79-85.
108. Shah, N.P. (1993). Effectiveness of dairy products in alleviation of lactose intolerance. Food Australia, 45, 268-270.
109. Shah, N.P. (2000). Effects of milk-derived bioactives: an overview. British Journal of Nutrition, 84(Suppl.), 3s-10s.
110. Shah, N.P. (2004). Probiotics and prebiotocs. Agro Food Industry HiTech, 15, 13-16.
111. Shah, N.P. (2007). Functional cultures and health benefits. International Dairy Journal, 17, 1262-1277.
112. Shah, N.P., Fedorak, R.N. & Jelen, P. (1992). Food consistency effects of quarq in lactose absorption by lactose intolerant individuals. International Dairy Journal, 2, 257-269.
113. Shanahan, F. (2000). Immunology. Therapeutic manipulation of gut flora. Science, 289, 1311-1312.
114. Shanahan, F. (2002). Crohn's disease. Lancet, 359, 62-69.
115. Shimakawa, Y., Matsubara, S., Yuki, N., Ikeda, M. & Ishikawa, F. (2003). Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. International Journal of Food Microbiology, 81, 131-136.
116. Singh, J., Rivenson, A., Tomita, A., Shimamura, S., Ishibashi, N. & Reddy, B.S. (1997). Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis, 18, 833-841.
117. Stanton, C., Gardiner, G., Lynch, P.B., Collins, J.K., Fitzgerald, G. & Ross, R.P. (1998). Probiotic cheese. International Dairy Journal, 8, 491-496.
118. Sultana, K., Godward, G., Reynolds, N., Arumgaswamy, R., Peiris, P. & Kailaspathy, K. (2000). Encapsulation of probiotic bacteria with alginate-starch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt. International Journal of Food Microbiology, 62, 47-55.
119. Surawicz, C.M., McFarland, L.V., Greenberg, R.N., Rubin, M., Fekety, R., Mulligan, M.E., Garcia, R.J., Brandmarker, S., Bowen, K., Borjal, D. & Elmer, G.W. (2000). The search for better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharmomyces bulardii. Clinical Infectious Diseases, 31, 1012-1017.
120. Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., Weber, J., Hoffmann, U. & Schreiber, S. (2002). Mucosal flora in inflammatory bowel disease. Gastroenterology, 122, 44-54.
121. Szajewska, H., Kotowska, M., Mrukowicz, J.Z., Armanska, M. & Mikolajczyk, W. (2001). Efficacy of Lactobacillus GG in prevention of nosocomial diarhea in infants. Journal of Pediatric, 138, 361-365.
122. Szajewska, H. & Mrukowicz, J.Z. (2001). Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of Publisher randomized, double-blind, placebocontrolled trials. Journal of Pediatric Gastroenterology and Nutrition, 33(Suppl. 2), 17s-25s.
123. Työppönen, S., Petäjä, E. & Mattila-Sandholm, T. (2003). Bioprotectives and probiotics for dry sausages. International Journal of Food Microbiology, 83, 233-244.
124. van den Heuvel, E.G.H.M., Muijs, T., van Dokkum, W. & Schaafsmam, G. (1999). Lactulose stimulates calcium absorption in postmenopausal women. Journal of Bone Mineral Research, 14, 1211-1216.
125. van den Heuvel, E.G.H.M., Schoterman, M.H. & Muijs, T. (2000). Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. Journal of Nutrition, 130, 2938-2942.
126. Van Niel, C.W., Feudtner, C., Garrison, M.M. & Christakis, D.A. (2002). Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics, 109, 678-684.
127. Vergio, F. (1954). Anti- und Probiotika. Hippocrates, 25, 116-119.
128. Wollowski, I., Rechkemmer, G. & Pool-Zobel, B.L. (2001). Protective role of probiotics and prebiotics in colon cancer. American Journal of Clinical Nutrition, 73(Suppl.), s451-s545.
129. Wullt, M., Hagslatt, M.L. & Odenholt, I. (2003). Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhea: a double-bind, placebo-controlled trial. Scandinavian Journal of Infectious Diseases, 35, 365-367.
130. Yoon, K.Y., Woodams, E.E. & Hang, Y.D. (2007). Production of probiotic cabbage juice by lactic acid bacteria. Bioresource Technology, 7, 1427-1430.